论文期刊

取消

高级检索

检索历史清除

首页> Frontiers in immunology> Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital.

Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital.

导出 LinkOut

翻译打印收藏纠错

作者： Vidya,Arankalle ^[1] ; Archana,Kulkarni-Munje ^[1] ; Ruta,Kulkarni ^[1] ; Sonali,Palkar ^[2] ; Rahul,Patil ^[1] ; Jitendra,Oswal ^[2] ; Sanjay,Lalwani ^[2] ; Akhilesh Chandra,Mishra ^[3]

作者单位： Department of Communicable Diseases, Interactive Research School for Health Affairs, Bharati Vidyapeeth (Deemed to be) University, Pune, Maharashtra, India. ^[1] Department of Pediatrics, Bharati Vidyapeeth Medical College, Bharati Vidyapeeth (Deemed to be) University, Pune, Maharashtra, India. ^[2] Bharati Vidyapeeth Medical College, Bharati Vidyapeeth (Deemed to be) University, Pune, Maharashtra, India. ^[3]

关键词 COVAXIN COVISHIELD SARS CoV-2 T cell response immunogenicity

主题词抗体, 中和(Antibodies, Neutralizing);队列研究(Cohort Studies);酶联免疫斑点测定(Enzyme-Linked Immunospot Assay);卫生人员(Health Personnel);人类(Humans);免疫球蛋白G(Immunoglobulin G);疾病大流行(Pandemics);疫苗, 灭活(Vaccines, Inactivated)

DOI 10.3389/fimmu.2022.928501

PMID 36211366

发布时间 2022-10-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in immunology

928501页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷